Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of F<sub>O</sub>F<sub>1</sub>-ATP synthase.

Front Pharmacol · 2022 · PMC9615146 · PMID 36313289

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Thus, these results suggest that α TP and β TP exhibit a clear trend to interact with each other towards the adoption of an α DP /β DP -like conformation.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.